Managing director Masaaki Kotaki, who has served Daiichi Sankyo for three decades, said the company believes Australia represents a significant opportunity.
Daiichi Sankyo continues Australian growth trajectory
October 23, 2024 Latest NewsBioPharma'MyBioPharmaSpace'Latest Video
New Stories
-
The health department's strategy is based on the 'hope' that sponsors do not submit and enforce their rights
October 24, 2024 - - Latest News -
Health department attempts to defer two-thirds of submissions to March meeting
October 24, 2024 - - Latest News -
Release of white paper from NZ's Valuing Life Medicines Access Summit
October 24, 2024 - - Latest News -
This has happened before, there was consultation, and it was managed without harming patients
October 23, 2024 - - Latest News -
Companies should reject the letters and proceed with their submissions
October 23, 2024 - - Latest News -
'Our job as advocates is to interpret what patients mean by hope, not to ignore it'
October 23, 2024 - - Latest News -
Daiichi Sankyo continues Australian growth trajectory
October 23, 2024 - - Latest News